DERM - Journey Medical Corp
IEX Last Trade
4.11
0 0%
Share volume: 1
Last Updated: Fri 27 Dec 2024 08:09:42 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.90%
PREVIOUS CLOSE
CHG
CHG%
$4.11
0.00
0.00%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-10 | 2023-03-31 | 2023-05-22 | 2023-08-10 | 2023-11-13 | 2024-03-29 | 2024-05-14 | |
| Assets | |||||||||
| Total Assets | 113.496 M | 108.145 M | 105.160 M | 95.853 M | 69.747 M | 65.918 M | 76.849 M | 66.571 M | |
| Current Assets | 83.901 M | 79.596 M | 77.679 M | 60.720 M | 47.679 M | 44.686 M | 56.455 M | 47.013 M | |
| Inventories | 16.053 M | 15.230 M | 14.159 M | 13.278 M | 12.166 M | 11.024 M | 10.206 M | 10.580 M | |
| Other Current Assets | 1.035 M | 942.000 K | 3.309 M | 2.477 M | 1.796 M | 924.000 K | 3.588 M | 2.577 M | |
| Short Term Investments | 1.035 M | 942.000 K | 3.309 M | 2.477 M | 1.796 M | 924.000 K | 3.588 M | 2.577 M | |
| Total Receivables | 28.671 M | 28.533 M | 28.208 M | 27.616 M | 16.737 M | 7.989 M | 15.222 M | 9.799 M | |
| Current Cash | 38.142 M | 34.891 M | 32.003 M | 17.349 M | 8.230 M | 24.749 M | 27.439 M | 24.057 M | |
| Total Non-current Assets | 29.595 M | 28.549 M | 27.481 M | 35.133 M | 22.068 M | 21.232 M | 20.394 M | 19.558 M | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 155.000 K | 125.000 K | 284.000 K | 255.000 K | 152.000 K | 130.000 K | 107.000 K | 85.000 K | |
| Intangible Assets | 29.440 M | 28.424 M | 27.197 M | 26.128 M | 21.916 M | 21.102 M | 20.287 M | 19.473 M | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 113.496 M | 108.145 M | 105.160 M | 95.853 M | 69.747 M | 65.918 M | 76.849 M | 66.571 M | |
| Total liabilities | 78.701 M | 81.961 M | 88.178 M | 88.361 M | 69.742 M | 48.544 M | 56.499 M | 53.620 M | |
| Total current liabilities | 60.100 M | 60.777 M | 66.832 M | 76.898 M | 68.193 M | 48.510 M | 41.868 M | 38.936 M | |
| Accounts Payable | 32.750 M | 33.626 M | 36.570 M | 43.658 M | 31.773 M | 28.164 M | 18.149 M | 15.343 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 2.677 M | 4.223 M | 5.275 M | 15.295 M | 12.370 M | 3.097 M | 3.099 M | 3.084 M | |
| Long term debt | 18.601 M | 21.184 M | 21.346 M | 11.463 M | 1.549 M | 34.000 K | 14.631 M | 14.684 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 34.795 M | 26.184 M | 16.982 M | 7.492 M | 5.000 K | 17.374 M | 20.350 M | 12.951 M | |
| Common stock | 17.456 M | 17.618 M | 17.733 M | 17.807 M | 18.005 M | 18.416 M | 18.701 M | 19.757 M | |
| Retained earnings | -47.780 M | -57.860 M | -68.502 M | -78.638 M | -87.001 M | -70.212 M | -72.355 M | -82.797 M |